Clinical Report: Feasibility of Helical Tomotherapy for Lung Irradiation

Overview

This case series evaluates the feasibility and short-term outcomes of Helical Tomotherapy (HT) for whole lung irradiation (WLI) with simultaneous integrated boost (SIB) in patients with pulmonary metastatic Ewing’s sarcoma. The findings indicate high response rates and manageable toxicity, highlighting the potential of HT in complex clinical scenarios.

Background

Ewing’s sarcoma is a significant malignancy in children and adolescents, often metastasizing to the lungs, which adversely affects prognosis. Whole-lung irradiation is crucial for improving survival but poses risks of cardiac toxicity with conventional techniques. Helical Tomotherapy offers a promising alternative by enhancing target conformity and sparing surrounding organs.

Data Highlights

Key Findings

• Overall response rate was 86.7% across 68 lesions.
• Median follow-up duration was 5.5 months.
• One patient experienced grade 3 radiation pneumonitis, which resolved with steroids.
• Mean heart dose was 7.39 ± 0.81 Gy, indicating effective cardiac sparing.
• Lung V20 was 19.15 ± 5.03%, demonstrating satisfactory organ-at-risk sparing.

Clinical Implications

Helical Tomotherapy for WLI with SIB is feasible and shows promising short-term efficacy in patients with pulmonary metastatic Ewing’s sarcoma. Clinicians should remain vigilant regarding the risk of radiation pneumonitis, especially when combined with immunotherapy.

Conclusion

HT-based WLI with SIB demonstrates excellent target coverage and manageable toxicity in complex cases of pulmonary metastatic Ewing’s sarcoma, warranting further investigation in larger cohorts.

Related Resources & Content

1. Evaluation of Toxicity in Anal Cancer Patients Receiving Definitive Simultaneous Integrated Boost (SIB) Versus Sequential Integrated Boost (SeqB) Radiotherapy, Springer, 2023 -- Evaluation of Toxicity in Anal Cancer Patients
2. Electrochemotherapy for Managing Bone Metastases: Results from a Phase II Study, Springer, 2016 -- Electrochemotherapy for Managing Bone Metastases
3. Primary Lung Tumor SBRT Followed by Concurrent Mediastinal Chemoradiotherapy and Immunotherapy Consolidation in Locally Advanced NSCLC, The ASCO Post, 2024 -- Primary Lung Tumor SBRT Followed by Concurrent Mediastinal Chemoradiotherapy
4. Whole Lung Irradiation in Ewing Sarcoma with Pulmonary Metastases: Critical Appraisal of Evolution, Evidence, and Future Pathways in Precision Oncology, Springer, 2026 -- Whole Lung Irradiation in Ewing Sarcoma
5. The ASCO Post — Lung Cancer Webinar Highlights Brain Metastases and Thoracic Radiotherapy
6. EE2012 PROTOCOL RADIOTHERAPY
7. Whole Lung Irradiation in Ewing Sarcoma with Pulmonary Metastases: Critical Appraisal of Evolution, Evidence, and Future Pathways in Precision Oncology | Current Treatment Options in Oncology | Springer Nature Link